Original Research
Accepted on 28 Apr 2026
Exploring the Celecoxib–Cervical Cancer Relationship Using In Vitro, Network Pharmacology, and Mendelian Randomization Approaches
in Obstetrics and Gynecology
Frontiers in Medicine
- 195 views
75 articles related to "Celecoxib"
Articles
Original Research
Published on 28 Jul 2015
Repurposing celecoxib as a topical antimicrobial agent
in Antimicrobials, Resistance and Chemotherapy
Frontiers in Microbiology
doi 10.3389/fmicb.2015.00750
- 15,081 views
- 87 citations
Original Research
Published on 21 Oct 2020
Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models
in Gastrointestinal Cancers
Frontiers in Oncology
doi 10.3389/fonc.2020.572861
- 5,369 views
- 7 citations
Original Research
Published on 22 Jul 2020
Metformin Synergistically Enhanced the Antitumor Activity of Celecoxib in Human Non-Small Cell Lung Cancer Cells
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2020.01094
- 7,212 views
- 18 citations
Original Research
Published on 07 Jun 2019
Celecoxib Protects Hyperoxia-Induced Lung Injury via NF-κB and AQP1
in Pediatric Pulmonology
Frontiers in Pediatrics
doi 10.3389/fped.2019.00228
- 4,346 views
- 23 citations
Original Research
Published on 19 Jan 2024
Celecoxib ameliorates diabetic sarcopenia by inhibiting inflammation, stress response, mitochondrial dysfunction, and subsequent activation of the protein degradation systems
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1344276
- 11,748 views
- 36 citations
Original Research
Published on 08 Nov 2024
Celecoxib and rofecoxib have different effects on small intestinal ischemia/reperfusion injury in rats
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1468579
- 3,040 views
- 3 citations
Clinical Trial
Published on 26 Aug 2022
Etanercept/celecoxib on improving MRI inflammation of active ankylosing spondylitis: A multicenter, open-label, randomized clinical trial
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2022.967658
- 6,636 views
- 5 citations
Review
Published on 26 Nov 2025
Celecoxib in oncology: targeting the COX-2/PGE2 axis to reprogram the tumor immune microenvironment and enhance multimodal therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1691392
- 3,879 views
- 5 citations
Original Research
Published on 30 May 2017
CD24 Expression Is Increased in 5-Fluorouracil-Treated Esophageal Adenocarcinoma Cells
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2017.00321
- 4,724 views
- 9 citations
Original Research
Published on 13 Dec 2011
Phase I Study of Celecoxib with Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients with Unresectable Locally Advanced Non-Small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2011.00052
- 7,373 views
- 12 citations
Original Research
Published on 19 Mar 2025
Celecoxib prevents malignant progression of smoking-induced lung tumors via suppression of the COX-2/PGE2 signaling pathway in mice
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1557790
- 5,863 views
- 5 citations
Clinical Trial
Published on 07 Aug 2018
Protective Effect of Celecoxib on Early Postoperative Cognitive Dysfunction in Geriatric Patients
in Neurodegeneration
Frontiers in Neurology
doi 10.3389/fneur.2018.00633
- 7,636 views
- 43 citations
Original Research
Published on 13 Feb 2017
High Kynurenine (a Tryptophan Metabolite) Predicts Remission in Patients with Major Depression to Add-on Treatment with Celecoxib
in Mood Disorders
Frontiers in Psychiatry
doi 10.3389/fpsyt.2017.00016
- 7,613 views
- 44 citations
Review
Published on 31 May 2019
COX-2 Inhibitors, Aspirin, and Other Potential Anti-Inflammatory Treatments for Psychiatric Disorders
in Molecular Psychiatry
Frontiers in Psychiatry
doi 10.3389/fpsyt.2019.00375
- 23,506 views
- 117 citations
Original Research
Published on 08 May 2017
Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens
in Antimicrobials, Resistance and Chemotherapy
Frontiers in Microbiology
doi 10.3389/fmicb.2017.00805
- 22,975 views
- 18 citations